AIOCD AWACS, Health News, ET HealthWorld

Pharma sales grow 51% in April: AIOCD AWACSSales of medicines by top pharma companies across India witnessed a robust growth of 51.5% in April. The growth was further fuelled by robust sales of drugs used — directly and indirectly — in the treatment of Covid-19, stated AIOCD AWACS, a pharma market research firm.

The overall drug sales in the domestic market jumped at Rs 15,662 crore in April as compared to Rs 10,337 crore in the same month last year.

“Covid second wave has further boosted the sales of drugs having direct or indirect role in treatment. Companies operating in Covid treatment therapy segments have gained substantially through bumper sales for the month,” the research further added in its monthly update.

The industry players, however, also maintained that the growth rate looks higher because the overall sales were very low in April last year on account of the nationwide lockdown in that month.

Follow and connect with us on , Facebook, Linkedin

Leave A Reply

Your email address will not be published.